BIODANE PHARMA A/S: Financial statements 2012
CVR: 28310102
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 384,418 and a net result of DKK 8,087. Equity in the 2012 report amounted to DKK 713,510. The solvency ratio was 60.4%.
- Gross Profit
- DKK 384,418
- Profit/Loss
- DKK 8,087
- Equity
- DKK 713,510
- Total Assets
- DKK 1,182,273
Official annual report
Keep an eye on BIODANE PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The company was previously named BIODANE PHARMA ApS and BIOFIBER TØRRING ApS. The management consists of Gunner Kreutzer Jakobsen. The board consists of Peter Gæmelke (chair), Flemming Torben Heden Knudsen, Gunner Kreutzer Jakobsen and Rasmus Juhl Rasmussen. The company is owned by BIODAN A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity in the 2025 report amounted to DKK 2,505,002.